# Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury

> **NCT05054803** · PHASE1,PHASE2 · COMPLETED · sponsor: **Banc de Sang i Teixits** · enrollment: 18 (actual)

## Conditions studied

- Spinal Cord Injury Cervical

## Interventions

- **DRUG:** WJ-MSC (XCEL-UMC-BETA)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05054803
- **Lead sponsor:** Banc de Sang i Teixits
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-13
- **Primary completion:** 2024-01-20
- **Final completion:** 2024-01-20
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-01-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05054803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05054803, "Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05054803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*